Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Metastatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00054145
What this trial is testing

Perifosine in Treating Patients With Recurrent, Refractory, Locally Advanced, or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
University Health Network, Toronto
Testing effectiveness (Phase 2)Study completedNCT00251472
What this trial is testing

A Phase II Trial of Abraxane™ Given Weekly as a Single Agent in First-line Treatment of Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Veeda Oncology 72
Large-scale testing (Phase 3)Active Not RecruitingNCT06316531
What this trial is testing

A Study Comparing BL-M07D1 With T-DM1 in Patients With Unresectable Locally Advanced or Metastatic HER2-positive Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 274
Not applicableStudy completedNCT01935102
What this trial is testing

Polymorphism Interaction to Predict Bevacizumab Efficacy

Who this might be right for
Metastatic Breast Cancer
University of Pisa 169
Testing effectiveness (Phase 2)Ended earlyNCT04251169
What this trial is testing

Pembrolizumab + Paclitaxel in HR+/HER2- Non-luminal (by PAM50) Advanced Breast Cancer After CDK4/6 Inhibitor Progression

Who this might be right for
Metastatic Breast Cancer
SOLTI Breast Cancer Research Group 20
Testing effectiveness (Phase 2)Study completedNCT00005873
What this trial is testing

Nitrocamptothecin in Treating Patients With Locally Recurrent or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Astex Pharmaceuticals, Inc.
Early research (Phase 1)Study completedNCT06126575
What this trial is testing

A PK Study Testing Single Oral Dose of Elacestrant in Subjects With Normal or Severely Impaired Hepatic Function

Who this might be right for
Hepatic Impairment
Stemline Therapeutics, Inc. 16
Early research (Phase 1)Study completedNCT01576666
What this trial is testing

Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors

Who this might be right for
Dose EscalationSafetyPreliminary Efficacy+9 more
Novartis Pharmaceuticals 120
Very early researchLooking for participantsNCT04265872
What this trial is testing

Bortezomib Followed by Pembrolizumab and Cisplatin in metTNBC

Who this might be right for
Breast Cancer
Baylor Research Institute 20
Not applicableStudy completedNCT05572645
What this trial is testing

Pyrotinib Plus Trastuzumab Versus Pertuzumab Plus Trastuzumab

Who this might be right for
Breast Cancer
Fudan University 333
Post-approval studies (Phase 4)UnknownNCT05131841
What this trial is testing

Cipterbin Combined With Vinorelbine in the Treatment of HER2-positive MBC

Who this might be right for
Metastatic Breast Cancer
Zhejiang Cancer Hospital 60
Early research (Phase 1)Ended earlyNCT05274451
What this trial is testing

Investigate LYL797 in Adults With Solid Tumors

Who this might be right for
Triple Negative Breast CancerTNBC - Triple-Negative Breast CancerNon-small Cell Lung Cancer+20 more
Lyell Immunopharma, Inc. 57
Testing effectiveness (Phase 2)UnknownNCT01231802
What this trial is testing

Study of Eniluracil + 5-Fluorouracil (5-FU) + Leucovorin Versus Capecitabine in Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Adherex Technologies, Inc. 140
Testing effectiveness (Phase 2)Ended earlyNCT03051672
What this trial is testing

Phase II PEMBROLIZUMAB + PALLIATIVE RADIOTHERAPY IN BC

Who this might be right for
Metastatic Breast Cancer
Dana-Farber Cancer Institute 8
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07005583
What this trial is testing

Clinical Study of QL1706 in Combination With Olaparib for the Treatment of Patients With Previously Treated Homologous Recombination Repair-Deficient Recurrent or Metastatic Triple-Negative Breast Cancer

Who this might be right for
Triple-Negative Breast Cancer (TNBC)
Tianjin Medical University Cancer Institute and Hospital 46
Early research (Phase 1)Study completedNCT01624441
What this trial is testing

Dinaciclib and Epirubicin Hydrochloride in Treating Patients With Metastatic Triple-Negative Breast Cancer

Who this might be right for
Estrogen Receptor NegativeHER2/Neu NegativeMale Breast Carcinoma+4 more
National Cancer Institute (NCI) 40
Early research (Phase 1)Study completedNCT00014456
What this trial is testing

Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors

Who this might be right for
Bladder CancerBreast CancerCarcinoma of Unknown Primary+9 more
Dartmouth-Hitchcock Medical Center 35
Early research (Phase 1)Study completedNCT00732056
What this trial is testing

GRN163L With Paclitaxel and Bevacizumab to Treat Patients With Locally Recurrent Or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Geron Corporation 24
Testing effectiveness (Phase 2)Study completedNCT00191373
What this trial is testing

A Trial for HER2 Positive Breast Cancer Patients With Metastatic Disease

Who this might be right for
Breast NeoplasmsCancer of the BreastBreast Cancer
Eli Lilly and Company 66
Testing effectiveness (Phase 2)Ended earlyNCT00465673
What this trial is testing

Liposomal Doxorubicin (Lipo-Dox) in Patients With Brain Metastasis From Breast Cancer

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2
Next Page